Clinical Trials Logo

Clinical Trial Summary

Introduction. Systemic lupus erythematosus is an autoimmune disease. The musculoskeletal system is affected in 90% of patients. The most common manifestations are myalgias, arthralgias and arthritis. Objective. To analyse the efficacy of an intervention using myofascial techniques and proprioceptive neuromuscular facilitation in patients with systemic lupus erythematosus. Methods. Randomised clinical study with 20 patients with systemic lupus erythematosus, randomised to an experimental and control group. The intervention will last 4 weeks, with a periodicity of 2 weekly sessions of 50 minutes each. The intervention of the experimental group will consist of a protocol using myofascial and proprioceptive neuromuscular facilitation techniques. Expected results. Improvement of knee and ankle pain intensity, functional capacity, basic mobility skills, strength, balance, agility and fatigue.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06383104
Study type Interventional
Source Universidad Católica San Antonio de Murcia
Contact Rubén Cuesta Barriuso, PhD
Phone 607547274
Email ruben.cuestab@gmail.com
Status Recruiting
Phase N/A
Start date April 22, 2024
Completion date June 26, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT04024306 - Steroid-induced Diabetes Mellitus in Systemic Lupus Erythematosus (SLE) Patients
Active, not recruiting NCT04018222 - Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic
Completed NCT04527172 - Neuromuscular Ultrasonography Utility for Detection of Peripheral Neuropathy in Systemic Lupus Erythematosus
Completed NCT05458531 - Monitoring of Inflammatory Conditions
Completed NCT04970199 - Cardiovascular Protective Role of Laser Acupuncture in Systemic Lupus N/A
Completed NCT03426384 - FLARE Lupus Research Study Systemic Lupus Erythematosus N/A
Recruiting NCT05984316 - Systemic Lupus Erythematosus N/A
Completed NCT03171194 - Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus Phase 1
Not yet recruiting NCT05314881 - NCF Gene & TNFSF4 in SLE Patients N/A
No longer available NCT04907175 - Individual Patient Expanded Access IND of Autologous HB-adMSCs for the Treatment of Systemic Lupus Erythematosus (SLE)